Loading company details...
Latest Form 4 (Nov 4, 2026): John R. Schroer (Chief Financial Officer): Sale of 794 shares, $5.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | John R. Schroer, Chief Financial Officer | Sale | 794 | $5.2K |
| Nov 4, 2026 | Sanam Pangali, Chief Legal Officer | Sale | 332 | $2.2K |
| Nov 4, 2026 | Roy C. Hardiman, Chief Business & Strategy Ofcr | Sale | 652 | $4.3K |
| Nov 4, 2026 | David M. Goldstein, Chief Scientific Officer | Sale | 629 | $4.1K |
| Nov 4, 2026 | Jorn Drappa, Chief Medical Officer | Sale | 593 | $3.9K |
| Nov 4, 2026 | Mark Christopher Bradley, Chief Development Officer | Sale | 623 | $4.1K |
| Sep 10, 2026 | Srinivas Akkaraju | Purchase | 220,070 | $2.46M |
| Aug 5, 2026 | John R. Schroer, Chief Financial Officer | Sale | 3,282 | $86.5K |
| Aug 5, 2026 | Sanam Pangali, Chief Legal Officer | Sale | 1,364 | $36.0K |
| Aug 5, 2026 | Roy C. Hardiman, Chief Business & Strategy Ofcr | Sale | 2,692 | $71.0K |